About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
N
Hot Topics in Heart Failure ACC.22
By
ACC 2022 Conference Coverage
FEATURING
Nasrien Ibrahim
April 22, 2022
3 Comments
Login to view comments.
Click here to Login
Featured Video
11:40
Novo Nordisk – GLP-1 RA Therapy
GLP-1 RA as a First Injectable for T2D: Is It as Effective as Basal …
Feat.
C. Wierum,
L. Coco
Featured Video
09:16
Novo Nordisk – GLP-1 RA Therapy
T2D Treatment After Metformin: What Does This GLP-1 RA Head-to-Head …
Feat.
R. Pratley
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
11:25
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
Feat.
A. Armbruster
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
17:44
Rita Jermyn
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
13:07
Michelle Kittleson
2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …
09:52
AHA 2022 Conference Coverage
AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…
Feat.
R. Mentz
22:48
Scripps Health
Heart Failure with Preserved Ejection Fraction: New Treatments
Feat.
R. C. Mohan
35:16
Scripps Health
HFpEF or Amyloidosis? The Right Therapies for Right Patients
Feat.
M. Kittleson
18:05
The Texas Heart Institute
Inside the Studio w/ Dr. Stephanie Coulter | Dr. Darren McGuire
Feat.
S. Coulter,
D. K. Mcguire
30:07
MUSC Cardiology
Hypertrophic Cardiomyopathy as a Form of HFpEF: Diagnosis, Drugs and…
Feat.
J. Atkins
84:17
Jefferson Health
2022 Heart Failure Guidelines Review
Feat.
D. Haas
22:46
Houston Methodist DeBakey Heart and Vascular Center
COVID-19 and Heart Failure: How to Evaluate Patients? Can You Give B…
Feat.
N. Fida
34:18
Scripps Health
Cancer Survivorship: How To Monitor for Cardiac Disease Following Tr…
Feat.
A. Kuo
27:25
MUSC Cardiology
2023 Update on Cardiac Amyloid
Feat.
J. Griffin
10:02
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…
Feat.
G. Umpierrez
13:42
George Bakris
Current Status of Prevention and Treatment of Diabetic Nephropathy
11:50
American Heart & Vascular Institute
New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …
Feat.
M. Kittleson
